 |
submitted by /u/anutensil [link] [comments] |
Feds launch probe into Project Nightingale, which secretly gave Google access to Americans' medical data
With Few New Drugs To Treat Antibiotic Resistance, How Best To Deploy Them? - Infection specialists debate whether it's better to aim all their strongest antibiotics at once at multi-resistant germs, or save the most innovative drugs for use only as a last result.
With Few New Drugs To Treat Antibiotic Resistance, How Best To Deploy Them? - Infection specialists debate whether it's better to aim all their strongest antibiotics at once at multi-resistant germs, or save the most innovative drugs for use only as a last result.
https://ift.tt/32HOfCE November 13, 2019 at 05:20PM https://ift.tt/1R552o9
 |
submitted by /u/anutensil [link] [comments] |
Feds launch probe into Project Nightingale, which secretly gave Google access to Americans' medical data
Feds launch probe into Project Nightingale, which secretly gave Google access to Americans' medical data
https://ift.tt/2NJGg3W November 13, 2019 at 05:18PM https://ift.tt/1R552o9
|
submitted by /u/anutensil [link] [comments] |
Flesh-eating infection caused by two microbe strains discovered by doctors, causing the patient to require quadruple amputations after developing rare condition, as reported in the journal PNAS. Neither strain of the bacteria was dangerous on its own, but combination of both was potentially lethal.
Flesh-eating infection caused by two microbe strains discovered by doctors, causing the patient to require quadruple amputations after developing rare condition, as reported in the journal PNAS. Neither strain of the bacteria was dangerous on its own, but combination of both was potentially lethal.
https://ift.tt/2NJwHBW November 13, 2019 at 04:23PM https://ift.tt/1R552o9
 |
submitted by /u/mvea [link] [comments] |
Flesh-eating infection caused by two microbe strains discovered by doctors, causing the patient to require quadruple amputations after developing rare condition, as reported in the journal PNAS. Neither strain of the bacteria was dangerous on its own, but combination of both was potentially lethal.
|
submitted by /u/mvea [link] [comments] |
J&J's Remicade losing ground in Quebec health plan despite court victory
J&J's Remicade losing ground in Quebec health plan despite court victory
Reuters: Health
Johnson & Johnson's Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec's public drug program, even after a court ruling reinstated full coverage in January, a Reuters analysis of government data shows.
Reuters: Health
Johnson & Johnson's Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec's public drug program, even after a court ruling reinstated full coverage in January, a Reuters analysis of government data shows.
Subscribe to:
Posts (Atom)